Black Diamond Therapeutics, Inc. (BDTX) stock
Close on Nov 12, 2026Market cap $87.33MP/E –Yield –
Black Diamond Therapeutics statistics
65 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 15, 2027 (estimated, during market hours)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 0.99
- 2.29
Share statisticsIndustry
- Shares Change (YoY)
- 0.81%
- 10.9%
- Shares Change (QoQ)
- 0.04%
- 0.51%
- Float
- 52M
- 49M
- Shares Held by Insiders
- 9.12%
- 12.1%
- Shares Held by Institutions
- 61.0%
- 56.4%
Short sellingIndustry
- Short Interest
- 5M
- –
- Short Interest Change
- 2.07%
- -0.76%
- Short % of Float
- 9.78%
- 9.04%
- Short % of Shares Outstanding
- 8.89%
- 6.30%
- Days to Cover
- 4.87
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $4.94
- –
- 52-Week Low
- $1.51
- –
- 20-Day Moving Average
- $1.80
- –
- 50-Day Moving Average
- $1.86
- –
- 200-Day Moving Average
- $2.15
- –
- Average True Range (14)
- $0.15
- –
- Price Change (1 Week)
- -8.43%
- 1.51%
- Price Change (1 Month)
- -10.6%
- -2.35%
- Price Change (3 Months)
- -24.8%
- -21.1%
- Price Change (6 Months)
- -46.9%
- -22.6%
- Price Change (YTD)
- -37.4%
- -22.6%
- Price Change (1 Year)
- -67.1%
- -20.7%
- Price Change (3 Years)
- -20.0%
- -27.4%
- Price Change (5 Years)
- -80.3%
- -77.3%
- Average Volume (10 Days)
- 691,544
- –
- Average Volume (20 Days)
- 901,276
- –
- Average Volume (90 Days)
- 693,611
- –
- Relative Volume
- 1.36
- 0.79
- Relative Strength Index (14)
- 38.8
- 44.7
- Volatility (1 Year)
- 83.0%
- 80.4%
- Beta (5 Years)
- 2.46
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -41.1%
- -51.2%
- Return on Assets (ROA)
- -32.3%
- -40.6%
- Return on Capital Employed (ROCE)
- -53.0%
- -38.0%
Financial positionIndustry
- Current Ratio
- 6.92
- 3.30
- Quick Ratio
- 6.62
- 2.42
GrowthIndustry
- Revenue Growth (YoY)
- -100.0%
- 7.01%
- Net Income Growth (YoY)
- -305.0%
- -14.4%
- EPS Growth (YoY)
- -311.1%
- -11.7%
EfficiencyIndustry
- Asset Turnover
- 0.00
- 0.40
- Revenue Per Employee
- $0
- $429.29K
- Profits Per Employee
- -$2.10M
- -$683.67K
- Employee Count
- 21
- 75
- WACC
- 17.3%
- 10.1%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $102.03M
- $17.46M
- Net Cash Per Share
- $1.78
- $0.72
- Equity (Book Value)
- $88.08M
- $53.27M
- Book Value Per Share
- $1.53
- $1.50
- Tangible Book Value
- $88.08M
- $26.82M
- Working Capital
- $91.14M
- $79.47M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- -50.5%
- -20.8%
Scores and fair valueIndustry
- Altman Z-Score
- -4.64
- 0.30
- Piotroski F-Score
- 7
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | BDTX | S&P 500 | Difference | BDTX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -14.1% | -2.7% | −11.4 pts | ||
| 3 months | -27.6% | -1.7% | −25.9 pts | ||
| Year to date | -37.4% | +11.9% | −49.3 pts | ||
| 1 year | -68.8% | +12.0% | −80.8 pts | ||
| 3 years | -14.6% | +78.2% | −92.8 pts | -5.1% | +21.2% |
| 5 years | -80.3% | +73.2% | −153.5 pts | -27.7% | +11.6% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
5M BDTX shares were sold short on Oct 30, 2026, up 2.1% from the previous report, or 9.78% of the shares available to trade. At recent volumes it would take 4.9 days to buy them back. Over the last 20 sessions, 65.2% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 5,106,005 | +2.1% | 1,049,276 | 4.9 |
| Oct 15, 2026 | 5,002,599 | +4.8% | 682,612 | 7.3 |
| Sep 30, 2026 | 4,775,586 | -7.2% | 653,622 | 7.3 |
| Sep 15, 2026 | 5,147,935 | -15.9% | 508,311 | 10.1 |
| Aug 31, 2026 | 6,119,016 | -1.1% | 562,866 | 10.9 |
| Aug 14, 2026 | 6,185,629 | +5.5% | 596,806 | 10.4 |
| Jul 31, 2026 | 5,862,939 | +0.2% | 674,266 | 8.7 |
| Jul 15, 2026 | 5,851,617 | +30.0% | 1,568,961 | 3.7 |
| Jun 30, 2026 | 4,502,074 | -9.7% | 2,547,230 | 1.8 |
| Jun 15, 2026 | 4,984,059 | -17.4% | 1,346,464 | 3.7 |
| May 29, 2026 | 6,033,281 | +14.5% | 3,536,856 | 1.7 |
| May 15, 2026 | 5,267,173 | +17.6% | 957,858 | 5.5 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?